drugset
drugset / Trial / NCT06067217

Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users

NCT06067217 ↗

Unknown 52 enrolled Department of Medical Services Ministry of Public Health of Thailand
RandomizedParallel-groupTriple-blindTreatment

Summary

Abnormal uterine bleeding is the most common problems to discontinue Depo-medroxyprogesterone acetate (DMPA) in Thailand. This clinical trial use to provide drug to stop abnormal uterine bleeding from DMPA

Timeline

Start
2023-09-30
Primary completion
2024-08-01
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 250 mg Oral
Subject estradiol valerate Unknown 1 mg Oral

Indications

No indication recorded.